BioSpace News Archive

Cognate BioServices, Inc., the premier commercial-ready global CDMO in the Cell and Gene Therapy industry, and Nucleus Biologics, LLC, The Cell Performance Company™, announced today a partnership for custom and commercial medias and delivery systems for Cell and Gene Therapy clients.

Delta Dental of Arkansas provided $27.4 million in direct COVID-19 relief funding in 2020 while also enacting rate holds, offering grace periods for premium payments, easing eligibility requirements for coverage, retaining its full workforce and facilitating telecommuting for most of its employees.

Nextech Systems, a leading healthcare technology solutions provider for specialty physician practices, today announced the acquisition of MyMedLeads, a patient engagement and marketing software company based in Austin, TX.

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2020 financial results on Thursday, February 25, 2021, after the market close.

Scientists from the J. Craig Venter Institute (JCVI) have discovered that Influenza A virus (IAV) is found in heart tissue after it has been cleared from the lungs in mouse models.

Transnetyx, Inc. announced today its collaboration with One Codex on an end-to-end microbiome sequencing and analysis service

Dr. Reddy’s Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) (NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Reddy’s”) and Global Response Aid FZCO (GRA) today announced results from an Avigan study on moderate-severe hospitalized COVID-19 patients in Kuwait.

Confluent Medical Technologies Inc. (“Confluent”) today announced an expansion of its supply agreement with Allegheny Technologies (ATI) related to the manufacture and supply of ELI Nitinol, a specialized metal alloy used primarily to produce high-performance minimally invasive medical devices and components. Under the revised agreement, Confluent will provide funding to increase the furnace capacity at ATI Spec

The St. Baldrick’s Foundation, the largest non-government funder of childhood cancer research grants, is proud to announce a new partnership with TeamConnor Childhood Cancer Foundation based in Dallas, Texas to support the best research to find cures and better treatments for kids with cancer.

Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders